A detailed history of King Luther Capital Management Corp transactions in Dexcom Inc stock. As of the latest transaction made, King Luther Capital Management Corp holds 145,867 shares of DXCM stock, worth $16.4 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares
145,867
Previous 116,153 25.58%
Holding current value
$16.4 Million
Previous $14.4 Million 40.37%
% of portfolio
0.09%
Previous 0.07%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

BUY
$114.22 - $140.1 $3.39 Million - $4.16 Million
29,714 Added 25.58%
145,867 $20.2 Million
Q4 2023

Feb 09, 2024

BUY
$75.49 - $124.16 $5.32 Million - $8.74 Million
70,433 Added 154.05%
116,153 $14.4 Million
Q3 2023

Nov 13, 2023

BUY
$86.06 - $137.93 $4,991 - $7,999
58 Added 0.13%
45,720 $4.27 Million
Q2 2023

Aug 10, 2023

BUY
$112.47 - $130.98 $224 - $261
2 Added 0.0%
45,662 $5.87 Million
Q1 2023

May 11, 2023

SELL
$104.0 - $122.92 $4,680 - $5,531
-45 Reduced 0.1%
45,660 $5.3 Million
Q4 2022

Feb 13, 2023

BUY
$84.98 - $122.67 $3,824 - $5,520
45 Added 0.1%
45,705 $5.18 Million
Q3 2022

Nov 10, 2022

SELL
$76.35 - $94.18 $3,054 - $3,767
-40 Reduced 0.09%
45,660 $3.68 Million
Q2 2022

Aug 11, 2022

BUY
$67.99 - $132.89 $2.33 Million - $4.55 Million
34,218 Added 298.01%
45,700 $3.41 Million
Q1 2022

May 11, 2022

BUY
$94.08 - $130.2 $1.01 Million - $1.4 Million
10,749 Added 1466.44%
11,482 $5.87 Million
Q4 2021

Feb 14, 2022

BUY
$129.87 - $162.82 $389 - $488
3 Added 0.41%
733 $394,000
Q3 2021

Nov 10, 2021

BUY
$106.71 - $143.18 $77,898 - $104,521
730 New
730 $399,000
Q1 2018

May 08, 2018

SELL
$13.06 - $18.54 $178,595 - $253,534
-13,675 Closed
0 $0
Q4 2017

Feb 12, 2018

SELL
$11.12 - $15.38 $8,006 - $11,073
-720 Reduced 5.0%
13,675 $785,000
Q3 2017

Nov 13, 2017

BUY
$11.36 - $18.98 $163,527 - $273,217
14,395
14,395 $704,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $43.5B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track King Luther Capital Management Corp Portfolio

Follow King Luther Capital Management Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of King Luther Capital Management Corp, based on Form 13F filings with the SEC.

News

Stay updated on King Luther Capital Management Corp with notifications on news.